2 mA transcranial direct current stimulation (tDCS) for Attention Deficit Hyperactivity Disorder (ADHD)
Study Summary
This trial is testing whether a home-based tDCS device can help improve symptoms of ADHD and cognitive control over a four week period. They are also testing whether there is a dose-dependent response to tDCS.
- Attention Deficit Hyperactivity Disorder (ADHD)
- Attention Deficit Hyperactivity Disorder (ADHD) - Inattentive Type
Video Summary
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: Week 1 - Week 8 of Study
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
2mA transcranial direct current stimulation
1 of 3
1mA transcranial direct current stimulation
1 of 3
Sham transcranial direct current stimulation
1 of 3
Experimental Treatment
Non-Treatment Group
60 Total Participants · 3 Treatment Groups
Primary Treatment: 2 mA transcranial direct current stimulation (tDCS) · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Massachusetts | 27.3% |
| Washington | 9.1% |
| Pennsylvania | 9.1% |
| Other | 54.5% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Massachusetts General Hospital | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 41.7% |
| Met criteria | 58.3% |
Why did patients apply to this trial?
- "I want to learn more about my disease and by contributing, we will be able to gain more insight."
- "I've tried ADHD medications along with therapy and while I have received some benefit, I still have major struggles with executive function, motivation, distractibility, among others."
How many prior treatments have patients received?
| 0 | 50.0% |
| 1 | 25.0% |
| 3+ | 25.0% |
What questions have other patients asked about this trial?
- "Do participants need to travel to the site?"
- Dubreuil-Vall, Laura, Giulio Ruffini, and Joan A. Camprodon. 2020. “Deep Learning Convolutional Neural Networks Discriminate Adult ADHD from Healthy Individuals on the Basis of Event-related Spectral EEG”. Frontiers in Neuroscience. Frontiers Media SA. doi:10.3389/fnins.2020.00251.
- Joan A Camprodon, MD MPH PhD 2022. "Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05354232.
Frequently Asked Questions
Does this research include geriatric participants?
"This research project is seeking participants aged 18 to 65." - Anonymous Online Contributor
Are there any available slots for participants in this research trial?
"Affirmative. The details found on clinicaltrials.gov suggest that this research project is presently recruiting individuals for the trial, which was first made public on July 1st 2022 and has been refreshed as recently as July 21st 2022. Sixty people are required to be enrolled at one medical site." - Anonymous Online Contributor
Could I potentially join this clinical trial?
"This clinical trial is seeking 60 male and female outpatients between the ages of 18-65 to participate. All potential enrollees must have been diagnosed with Attention Deficit Hyperactivity Disorder - Inattentive Type, or meet the criteria outlined in DSM-5 for such a diagnosis." - Anonymous Online Contributor
How many participants are accepted in this clinical trial?
"Affirmative, clinicaltrials.gov reports that this examination is currently enrolling participants. The trial was first advertised on July 1st 2022 and has since had its details amended. 60 volunteers are required from a single medical facility." - Anonymous Online Contributor